Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
COVID-19 in adults with dementia: clinical features and risk factors of mortality-a clinical cohort study on 125 patients.
Vrillon A, Mhanna E, Aveneau C, Lebozec M, Grosset L, Nankam D, Albuquerque F, Razou Feroldi R, Maakaroun B, Pissareva I, Cherni Gherissi D, Azuar J, François V, Hourrègue C, Dumurgier J, Volpe-Gillot L, Paquet C. Vrillon A, et al. Among authors: volpe gillot l. Alzheimers Res Ther. 2021 Apr 10;13(1):77. doi: 10.1186/s13195-021-00820-9. Alzheimers Res Ther. 2021. PMID: 33838684 Free PMC article.
Primary Progressive Aphasia in the Network of French Alzheimer Plan Memory Centers.
Magnin E, Démonet JF, Wallon D, Dumurgier J, Troussière AC, Jager A, Duron E, Gabelle A, de la Sayette V, Volpe-Gillot L, Tio G, Evain S, Boutoleau-Bretonnière C, Enderle A, Mouton-Liger F, Robert P, Hannequin D, Pasquier F, Hugon J, Paquet C; ePLM collaborators. Magnin E, et al. Among authors: volpe gillot l. J Alzheimers Dis. 2016 Oct 18;54(4):1459-1471. doi: 10.3233/JAD-160536. J Alzheimers Dis. 2016. PMID: 27589533
Distribution of Cerebrospinal Fluid Biomarker Profiles in Patients Explored for Cognitive Disorders.
Paquet C, Bouaziz-Amar E, Cognat E, Volpe-Gillot L, Haddad V, Mahieux F, Dekimeche S, Defontaines B, Chabriat H, Belin C, Texeira A, Goutagny S, Questel F, Azuar J, Sellier PO, Laplanche JL, Hugon J, Dumurgier J. Paquet C, et al. Among authors: volpe gillot l. J Alzheimers Dis. 2018;64(3):889-897. doi: 10.3233/JAD-180240. J Alzheimers Dis. 2018. PMID: 29966201
Clinical value of plasma ALZpath pTau217 immunoassay for assessing mild cognitive impairment.
Lehmann S, Schraen-Maschke S, Vidal JS, Delaby C, Buee L, Blanc F, Paquet C, Allinquant B, Bombois S, Gabelle A, Hanon O; BALTAZAR study group. Lehmann S, et al. J Neurol Neurosurg Psychiatry. 2024 Apr 24:jnnp-2024-333467. doi: 10.1136/jnnp-2024-333467. Online ahead of print. J Neurol Neurosurg Psychiatry. 2024. PMID: 38658136 Free article.
Plasma amyloid levels within the Alzheimer's process and correlations with central biomarkers.
Hanon O, Vidal JS, Lehmann S, Bombois S, Allinquant B, Tréluyer JM, Gelé P, Delmaire C, Blanc F, Mangin JF, Buée L, Touchon J, Hugon J, Vellas B, Galbrun E, Benetos A, Berrut G, Paillaud E, Wallon D, Castelnovo G, Volpe-Gillot L, Paccalin M, Robert PH, Godefroy O, Dantoine T, Camus V, Belmin J, Vandel P, Novella JL, Duron E, Rigaud AS, Schraen-Maschke S, Gabelle A; BALTAZAR study group. Hanon O, et al. Among authors: volpe gillot l. Alzheimers Dement. 2018 Jul;14(7):858-868. doi: 10.1016/j.jalz.2018.01.004. Epub 2018 Feb 17. Alzheimers Dement. 2018. PMID: 29458036 Free article.
What the COVID-19 pandemic entails for the management of patients with behavioral and psychological symptoms of dementia: experience in France.
Drunat O, Roche J, Kohler S, Julien V, Pascal S, Lenoir H, Soto-Martin M, Lepetit A, Volpe-Gillot L, Leclercq V, Romdhani M, Koskas P, Lebert F. Drunat O, et al. Among authors: volpe gillot l. Int Psychogeriatr. 2020 Nov;32(11):1361-1364. doi: 10.1017/S1041610220003567. Epub 2020 Sep 15. Int Psychogeriatr. 2020. PMID: 32930087 Free PMC article. No abstract available.
Plasma amyloid beta predicts conversion to dementia in subjects with mild cognitive impairment: The BALTAZAR study.
Hanon O, Vidal JS, Lehmann S, Bombois S, Allinquant B, Baret-Rose C, Tréluyer JM, Abdoul H, Gelé P, Delmaire C, Blanc F, Mangin JF, Buée L, Touchon J, Hugon J, Vellas B, Galbrun E, Benetos A, Berrut G, Paillaud E, Wallon D, Castelnovo G, Volpe-Gillot L, Paccalin M, Robert P, Godefroy O, Camus V, Belmin J, Vandel P, Novella JL, Duron E, Rigaud AS, Schraen-Maschke S, Gabelle A; BALTAZAR study group. Hanon O, et al. Among authors: volpe gillot l. Alzheimers Dement. 2022 Dec;18(12):2537-2550. doi: 10.1002/alz.12613. Epub 2022 Feb 20. Alzheimers Dement. 2022. PMID: 35187794
Testing the therapeutic effects of transcranial direct current stimulation (tDCS) in semantic dementia: a double blind, sham controlled, randomized clinical trial.
Sanches C, Levy R, Benisty S, Volpe-Gillot L, Habert MO, Kas A, Ströer S, Pyatigorskaya N, Kaglik A, Bourbon A, Dubois B, Migliaccio R, Valero-Cabré A, Teichmann M. Sanches C, et al. Among authors: volpe gillot l. Trials. 2019 Nov 20;20(1):632. doi: 10.1186/s13063-019-3613-z. Trials. 2019. PMID: 31747967 Free PMC article. Clinical Trial.
17 results